Cargando…

Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals

Accumulating studies implicate that the metformin (MET)- and oligofructose (OFS)-altered gut microbiota may play roles in the improvement of type 2 diabetes mellitus (T2DM) and obesity. However, whether the combined administration of OFS and MET could effectively affect the gut microbiota and improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingzhong, He, Rui, Zhang, Fengmei, Zhang, Jian, Lian, Shihai, Liu, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052043/
https://www.ncbi.nlm.nih.gov/pubmed/32158428
http://dx.doi.org/10.3389/fendo.2019.00939
_version_ 1783502784912424960
author Li, Qingzhong
He, Rui
Zhang, Fengmei
Zhang, Jian
Lian, Shihai
Liu, Hongxia
author_facet Li, Qingzhong
He, Rui
Zhang, Fengmei
Zhang, Jian
Lian, Shihai
Liu, Hongxia
author_sort Li, Qingzhong
collection PubMed
description Accumulating studies implicate that the metformin (MET)- and oligofructose (OFS)-altered gut microbiota may play roles in the improvement of type 2 diabetes mellitus (T2DM) and obesity. However, whether the combined administration of OFS and MET could effectively affect the gut microbiota and improve metabolic profiles remains unknown. Here, we randomized diet-induced obesity (DIO) rats to OFS, MET, or MET+OFS for 8 weeks and demonstrated that the combined administration of OFS+MET possessed potentiated effects on the glycemia, body weight, and gut microbiome. In addition, fecal samples from the MET and MET+OFS group were exchanged and transferred to germ-free rats induced by antibiotics. Not surprisingly, the glucose tolerance and serum levels of endotoxin, free fatty acids (FFA), tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), and interleukin-6 (IL-6) were all sustainably improved among OFS+MET fecal microbiota-treated DIO rats while the MET fecal microbiota-treated ones presented a relatively reverse trend. Furthermore, transfer of fecal samples from the rats after 8 weeks of treatment to antibiotics-treated germ-free mice significantly improved metabolic profiles, including glucose tolerance and weight reduction in mice that received MET+OFS-altered microbiota. In conclusion, the present study illustrated that the effects of OFS and MET combined treatment on gut microbiota, especially for the MET-induced side effect-related ones, and host metabolism were of greater magnitude than individual OFS or MET treatment in obese rats and mice. Therefore, it is likely that combined administration of OFS and MET may offer a novel and promising strategy for reducing side effects induced by MET and improving metabolic outcomes, particularly glycemia control and weight reduction.
format Online
Article
Text
id pubmed-7052043
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70520432020-03-10 Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals Li, Qingzhong He, Rui Zhang, Fengmei Zhang, Jian Lian, Shihai Liu, Hongxia Front Endocrinol (Lausanne) Endocrinology Accumulating studies implicate that the metformin (MET)- and oligofructose (OFS)-altered gut microbiota may play roles in the improvement of type 2 diabetes mellitus (T2DM) and obesity. However, whether the combined administration of OFS and MET could effectively affect the gut microbiota and improve metabolic profiles remains unknown. Here, we randomized diet-induced obesity (DIO) rats to OFS, MET, or MET+OFS for 8 weeks and demonstrated that the combined administration of OFS+MET possessed potentiated effects on the glycemia, body weight, and gut microbiome. In addition, fecal samples from the MET and MET+OFS group were exchanged and transferred to germ-free rats induced by antibiotics. Not surprisingly, the glucose tolerance and serum levels of endotoxin, free fatty acids (FFA), tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), and interleukin-6 (IL-6) were all sustainably improved among OFS+MET fecal microbiota-treated DIO rats while the MET fecal microbiota-treated ones presented a relatively reverse trend. Furthermore, transfer of fecal samples from the rats after 8 weeks of treatment to antibiotics-treated germ-free mice significantly improved metabolic profiles, including glucose tolerance and weight reduction in mice that received MET+OFS-altered microbiota. In conclusion, the present study illustrated that the effects of OFS and MET combined treatment on gut microbiota, especially for the MET-induced side effect-related ones, and host metabolism were of greater magnitude than individual OFS or MET treatment in obese rats and mice. Therefore, it is likely that combined administration of OFS and MET may offer a novel and promising strategy for reducing side effects induced by MET and improving metabolic outcomes, particularly glycemia control and weight reduction. Frontiers Media S.A. 2020-02-25 /pmc/articles/PMC7052043/ /pubmed/32158428 http://dx.doi.org/10.3389/fendo.2019.00939 Text en Copyright © 2020 Li, He, Zhang, Zhang, Lian and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Li, Qingzhong
He, Rui
Zhang, Fengmei
Zhang, Jian
Lian, Shihai
Liu, Hongxia
Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title_full Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title_fullStr Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title_full_unstemmed Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title_short Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
title_sort combination of oligofructose and metformin alters the gut microbiota and improves metabolic profiles, contributing to the potentiated therapeutic effects on diet-induced obese animals
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052043/
https://www.ncbi.nlm.nih.gov/pubmed/32158428
http://dx.doi.org/10.3389/fendo.2019.00939
work_keys_str_mv AT liqingzhong combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals
AT herui combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals
AT zhangfengmei combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals
AT zhangjian combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals
AT lianshihai combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals
AT liuhongxia combinationofoligofructoseandmetforminaltersthegutmicrobiotaandimprovesmetabolicprofilescontributingtothepotentiatedtherapeuticeffectsondietinducedobeseanimals